Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.
Possibilities of Chest Magnetic Resonance Imaging (MRI) in Diagnostics of COVID-19. The Use of MRI to Assess Lung Damage in Patients With Coronavirus Infection
1 other identifier
observational
25
1 country
1
Brief Summary
Since the onset of the COVID-19 pandemic, the importance of chest computed tomography (CT) in detecting signs of viral pneumonia has become clear from the literature. However, the increased patient flow creates an additional pressure on CT centers. We believe, the use of chest magnetic resonance imaging (MRI) can help to test patients for CОVID-19 when CT scan is not available. Lung MRI may be useful in routing a patient in a difficult epidemiological situation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2020
CompletedFirst Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2021
CompletedMarch 21, 2023
March 1, 2023
1.2 years
June 5, 2020
March 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of zones of pulmonary parenchyma corresponding to viral pneumonia detected by chest MRI in comparison with CT scan
Expected number - more than two zones
Upon completion, up to 1 year
Study Arms (2)
Patients with suspected pneumonia COVID-19
Chest MRI findings: bilateral, diffuse ground-glass opacity (GGO), consolidation, "crazy paving" pattern, pleuritis.
Patients with suspected pneumonia with COVID -19
Chest CT findings: bilateral, diffuse ground-glass opacity (GGO), consolidation, "crazy paving" pattern, pleuritis.
Interventions
Patients referred by the primary care physician with suspected pneumonia
Eligibility Criteria
All patients with suspected viral COVID-19 pneumonia will be included in the study
You may qualify if:
- A referral from the attending physician for a chest CT scan
- Suspected pneumonia
- Signed informed consent
- Over 18 years old
You may not qualify if:
- Pregnant or nursing women
- Presence of foreign implanted objects in the body at the scan level (including cardiac pacemakers, spine metalware)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
Moscow, 109029, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Research Officer
Study Record Dates
First Submitted
June 5, 2020
First Posted
June 9, 2020
Study Start
May 19, 2020
Primary Completion
July 19, 2021
Study Completion
December 20, 2021
Last Updated
March 21, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share